MICROBIAL FACTOR AND TOLL-LIKE RECEPTORS IN PATHOGENESIS OF ATHEROSCLEROSIS


Cite item

Full Text

Abstract

Lypopolysaccharides of gram-negative bacteria can interact with TLR4 with subsequent formation of atheromas. Mutational deletion of TLR4 decreases risk of development of atherosclerosis. Other bacterial ligands, in particular, peptidoglycan as well as endogenous ligands reacting with TLRs and emerging in microorganism under the action of stress factors can contribute to induction of atherosclerosis. It has been concluded, that reactions initiated by interaction of TLRs with exogenous and endogenous ligands lie in the basis of atherosclerosis pathogenesis.

Keywords

Full Text

МИКРОБНЫЙ ФАКТОР И ТОLL-ПОДОБНЫЕ РЕЦЕПТОРЫ В ПАТОГЕНЕЗЕ АТЕРОСКЛЕРОЗА
×

About the authors

V. M Bondarenko

Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia

V. G Likhoded

Gamaleya Research Institute of Epidemiology and Microbiology, Moscow, Russia

References

  1. Бондаренко В.М. Роль условно-патогенных бактерий кишечника в полиорганной патологии человека. М., Триада, 2007.
  2. Бондаренко В.М., Лиходед В.Г., Яковлев М.Ю. Определение эндотоксина грамотрицательных бактерий в крови человека. Журн. микробиол. 2002, 2: 83-89.
  3. Климов А.Н., Нагорнев В.А. Взгляд на решение проблемы атеросклероза. Вестн. РАМН. 1999, 9: 33-37.
  4. Ковальчук Л.В. Учение о воспалении в свете новых данных: развитие идей И.И.Мечникова. Журн. микробиол. 2008, 5, 10-15.
  5. Ковальчук Л.В., Хорева Р.В., Варивода А.С. Врожденные компоненты иммунитета: Tollподобные рецепторы в норме и при иммунопатологии. Там же. 2005, 4, 96-104.
  6. Лиходед В.Г., Мартынова В.Р. Роль Chlamydia pneumoniae в этиологии атеросклероза. Там же. 2000, 4 (прил.): 117-121.
  7. Лиходед В.Г., Аниховская И.А., Аполлонин А.В. и др. Fc-зависимое связывание эндотоксина грамотрицательных бактерий полиморфноя дерными лейкоцитами. Там же. 1996, 2: 76-79.
  8. Лиходед В.Г., Яковлев М.Ю. Роль эндотоксина кишечной микрофлоры в патогенезе атеросклероза. Там же. 2001, 6: 105-109.
  9. Лиходед В.Г., Ющук Н.Д., Яковлев М.Ю. Роль эндотоксина грамотрицательных бактерий в инфекционной и неинфекционной патологии. Арх. патол. 1996, 58, 2: 8-13.
  10. Лыкова Е.А., Бондаренко В.М., Воробьев А.А. и др. Бактериальная эндотоксинемия у детей с кишечными дисбактериозами. Журн. микробиол. 1999, 3: 67-70.
  11. Рябиченко Е.В., Бондаренко В.М. Роль кишечной бактериальной аутофлоры и ее эндотоксина в патологии человека. Там же. 2007, 3: 103-111.
  12. Чижиков Н.В., Лиходед В.Г., Светухин А.М., Яковлев М.Ю. Эндотоксин кишечной микрофлоры в клинике и патогенезе хронической ишемии нижних конечностей. Пенза, 2002.
  13. Шварц Я.Ш., Душкин М.И. Эндотоксинемия и атеросклероз. Рос. кардиол. журн. 2001, 30: 83-92.
  14. Aukrust P., Gullestad L., Ueland T. et al. Inflammatory and anti-inflammatory cytokines in chronic heart failure: potential therapeutic implications. Annab. Med. 2005, 37: 74-85.
  15. Blum A., Miller H. The role of inflammation in atherosclerosis. Isr. J. Med. Sci. 1996, 32: 1059-1065.
  16. Boyd J.H., Mathur S., Wang T. et al. Toll-like receptor stimulation in cardiomyocytes decreased contractility and initiates an NF-kB dependent inflammatory response. Cardiovasc. Res. 2006, 72 (3): 384-393.
  17. Cook D.N., Pisetsky D.S., Schwartz D.A. Tolllike receptors in the pathogenesis of human disease. Nature Immunol. 2004, 5 (10): 975-979.
  18. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997, 350: 430-436.
  19. Erridge C., Stewart J., Poxton I.R. Monocytes heterozygous for the Asp299Gly and Thr399 Ile mutations in the Toll-like receptor 4 gene show no deficit lipopolysaccharides signaling. J. Exp. Med. 2003, 197: 1787-1791.
  20. Fink M.P., Mythen M.G. The role of gut-derived endotoxin in pathogenesis of multiple organ desfunction. In: Endotoxin in health and disease. Brade et al. (ed.). N.Y., Basel, 1999, p. 854-864.
  21. Funk J., Feingold K., Moser A. et al. Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation. Atherosclerosis. 1993, 98: 67-82.
  22. Нoarau C., Lagaraine C., Martin L. et al. Supernatant of Bifidobacterium breve induced dendritic cell maturation, activation and survival through a Toll-like receptor 2 pathway. J. Allergy Clin. Immunol. 2006, 117 (3): 696-702.
  23. Ieven M.M., Hoymans V.Y. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J. Clin. Microbiol. 2005, 43 (1): 19-24.
  24. Jang I.K., Lassila R., Fuster V. Atherogenesis and inflammation. Eur. Heart J. 1993, 14 (suppl.): S2-S6.
  25. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harbor Symposium Quant Biology. 1989, 54: 1-13.
  26. Kalayoglu M.V., Byrne G.L. A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide. Infect. Immun. 1998, 66 (11): 5067- 5072.
  27. Lan J.G., Cruickhank S.M., Singh J.C. et al. Different cytokine response of primary colonic epithelial cеlls to commensal bacteriа. World J. Gastroenterol. 2005, 11 (22), 3375-3384.
  28. Liao W. Endotoxin: possible roles in initiation and development of аtherosclerosis. J. Lab. Clin. Med. 1996, 128 (5): 452-460.
  29. Li Liwu. Regulation of innate immunity signaling and its connection with human diseases. Current drug targets. Inflamm. Allerg. 2004, 3: 81-86.
  30. Maseri A. Inflammation, atherosclerosis and ischemic events — exploring the hidden side of the moon. N. Engl. J. Med. 1997, 336: 1014-1016.
  31. Murakami T., Yamada N. Modification of macrophage function and effects on atherosclerosis. Curr. Clin. Lipidol. 1996, 7: 320-323.
  32. Oiknine J., Aviram M. Increased susceptibility to activation and increased uptake of low density liloprotein by cholesterol-loaded macrophages. Artherioscler. Thromb. 1992, 12: 745-753.
  33. Pesonen E., Kaprio E., Rapola J. et al. Endothelial cell damage in piglet coronary artery after administ ration of E.coli endotoxin. Atherosclerosis. 1981, 40: 65-73.
  34. Qureshi S.T., Medzhitov R. Toll-like receptors and their role in experimental models of microbial infection. Gen. Immun. 2003, 4: 87-94.
  35. Rakoff-Wahoum S., Paglino J., Eslami-Varzaneh F. et al. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell. 2004, 118 (2): 229-241.
  36. Reidy M.A., Bowyer D.E. Scanning electron microscopy — morphology of aortic endothelium following injury by endotoxin and during subsequent repair. Atherosclerosis. 1977, 26: 319-325.
  37. Ridker P., Cushman M., Stampfer R. et al. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men. N. Engl. J. Med. 1997, 336: 973-979.
  38. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993, 362: 801-809.
  39. Satoh M., Shimoda Y., Akatsu T. et al. Elevated сirculating levels of heat shock protein 70 are related to systemic inflammation reaction through monocyte Toll signal in patients with heart failure after acute myocardial infarction. Eur. Soc. Cardiol. 2006, 8: 810-815.
  40. Stewart G.J., Anderson M.J. An ultrastructural study of endotoxin induced damage in rabbit mesenteric arteries. Brit. J. Exp.Pathol. 1971, 52: 75-80.
  41. Taranto M.P., Perdigon G., Medici M. et al. Animal model for in vivo evaluation of cholesterol reduction by lactic acid bacteria. Meth. Mol. Biol. 2004, 268: 417-422.
  42. Ulevitch R.J. Therapeutics targeting and innate immune system. Nature Rev. Immunol. 2002, 4: 512-520.
  43. Vidal K., Donnet-Hughes A., Granato D. Lipoteichoic acid from Lactobacillus johnsonii strain La1 and Lactobacillus acidophilus strain La10 antagomize the responsiveness of human intestinal epithelial HT29 cells to lipopolysaccharide and gramnegative bacteria. Infect. Immun. 2002, 70 (4): 2057-2064.
  44. Wallin R.P., Lundquist A., More S.H. et al. Heatshock proteins as activators of innate immune system. Trends Immunol. 2002, 23: 130-135.
  45. Wiederman C.J., Kiechl S., Dunzendorfer S. et al. Endotoxemia and atherosclerosis. J. Endotox. Res. 2000, 6, 2: 86-88.
  46. Xu Q., Dietrich H., Steiner H.J. et al. Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis. Circulation. 1999, 99 (12): 1560-1566.
  47. Xu Q., Willet J., Marosi M. et al. Association of serum antibodies to heat-shock protein 65 with atherosclerosis. Lancet. 1993, 341 (8840): 255-259.
  48. Yokude M., Kita T. The macrophage and its role in atherogenesis. Intern. Med. 1995, 34: 281-283.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Bondarenko V.M., Likhoded V.G.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: ПИ № ФС77-75442 от 01.04.2019 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies